IS2676B - 4-(2-fenýlsúlfanýl-fenýl)-píperidín afleiður sem serótónín endurupptöku hindrar - Google Patents

4-(2-fenýlsúlfanýl-fenýl)-píperidín afleiður sem serótónín endurupptöku hindrar

Info

Publication number
IS2676B
IS2676B IS7996A IS7996A IS2676B IS 2676 B IS2676 B IS 2676B IS 7996 A IS7996 A IS 7996A IS 7996 A IS7996 A IS 7996A IS 2676 B IS2676 B IS 2676B
Authority
IS
Iceland
Prior art keywords
phenylsulfanyl
phenyl
serotonin reuptake
piperidine derivatives
inhibit serotonin
Prior art date
Application number
IS7996A
Other languages
English (en)
Icelandic (is)
Other versions
IS7996A (is
Inventor
Ask Pueschl
Morten Jorgensen
Thomas Ruhland
Tine Bryan Stensboel
Benny Bang-Andersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36091716&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS2676(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/DK2004/000244 external-priority patent/WO2004087156A1/en
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of IS7996A publication Critical patent/IS7996A/is
Publication of IS2676B publication Critical patent/IS2676B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/24—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS7996A 2003-04-04 2005-08-22 4-(2-fenýlsúlfanýl-fenýl)-píperidín afleiður sem serótónín endurupptöku hindrar IS2676B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200300520 2003-04-04
PCT/DK2004/000244 WO2004087156A1 (en) 2003-04-04 2004-04-02 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors

Publications (2)

Publication Number Publication Date
IS7996A IS7996A (is) 2005-08-22
IS2676B true IS2676B (is) 2010-09-15

Family

ID=36091716

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7996A IS2676B (is) 2003-04-04 2005-08-22 4-(2-fenýlsúlfanýl-fenýl)-píperidín afleiður sem serótónín endurupptöku hindrar

Country Status (10)

Country Link
KR (1) KR101107536B1 (es)
CN (1) CN1780622A (es)
AR (1) AR043965A1 (es)
BR (1) BRPI0408647A (es)
CL (1) CL2004000725A1 (es)
EA (1) EA010869B1 (es)
IS (1) IS2676B (es)
NZ (1) NZ541859A (es)
UA (1) UA81472C2 (es)
ZA (1) ZA200507181B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200932225A (en) * 2007-12-14 2009-08-01 Lundbeck & Co As H 4-[2,3-difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine
CN105348204B (zh) * 2015-11-18 2018-09-14 乳源瑶族自治县大众药品贸易有限公司 1-杂环基-2-(杂芳基硫基)苯衍生物及其使用方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
US4198419A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenylthiophenylpiperidines
EA005671B1 (ru) * 1999-10-13 2005-04-28 Пфайзер Продактс Инк. Производные биариловых эфиров, полезные в качестве ингибиторов обратного захвата моноамина
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну

Also Published As

Publication number Publication date
AR043965A1 (es) 2005-08-17
EA010869B1 (ru) 2008-12-30
UA81472C2 (en) 2008-01-10
CN1780622A (zh) 2006-05-31
NZ541859A (en) 2008-10-31
EA200501577A1 (ru) 2006-04-28
KR20050119681A (ko) 2005-12-21
KR101107536B1 (ko) 2012-01-31
BRPI0408647A (pt) 2006-03-07
IS7996A (is) 2005-08-22
CL2004000725A1 (es) 2005-02-18
ZA200507181B (en) 2007-03-28

Similar Documents

Publication Publication Date Title
IS2732B (is) Fenýl-píperidín afleiður sem serótónín endurupptökuhindrar
IS8189A (is) Ný útskipt 3-brennisteinsindól
ATE479681T1 (de) Substituierte piperidine
IS7884A (is) Díasepínóindól afleiður sem kínasa hindrar
EP1720874A4 (en) SUBSTITUTED PIPERIDINE DERIVATIVES IN POSITION 4
NO20054224D0 (no) Nye 2-pyridinkarboksamidderivater
IL172063A0 (en) N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
EE200300478A (et) Tsüklopropüülindooli derivaadid kui selektiivsed serotoniini tagasihaarde inhibiitorid
DK1773810T3 (da) Hidtil ukendte 4-benzylidenpiperidinderivater
IS8007A (is) 4-(2-fenýlsúlfanýl-fenýl)-1,2,3,6-tetrahýdrópýridín afleiður sem serótónín endurupptöku hindrar
EP1870401A4 (en) SUBSTITUTE DERIVATIVE PIPERAZINE IN 1,4
IS6704A (is) Fenoxýbensýlamínafleiður sem valvísir serótónín endurupptöku hindrar
MA28801B1 (fr) Composition antihistaminique
DK1861389T3 (da) 7-(2-(4-(3-triflourmethylphenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl)isoquinoleinbesylatsalt
NL2000937A1 (nl) Piperidinederivaten.
IS6960A (is) Fenýl heterósýklýl eter afleiður sem serótónín endurupptökuhindrar
DE602004004387D1 (de) Kleiderbügel
IS7901A (is) 4-(2-Fenýloxýfenýl)-píperidín eða -1,2,3,6-tetrahýdrópýridín afleiður sem serótónín endurupptöku hindrar
DE602004010385D1 (de) 3,4-disubstituierte 1,2,3,4-tetrahydropyridinderivate
DK1656305T3 (da) Ny indretning
PL1710240T3 (pl) Pochodne piperazyny i ich zastosowanie jako inhibitorów ponownego wychwytu serotoniny lub jako antagonistów neurokininy
IS2676B (is) 4-(2-fenýlsúlfanýl-fenýl)-píperidín afleiður sem serótónín endurupptöku hindrar
IS2815B (is) 2-(1H-indólýlsúlfanýl)-bensýlamínafleiður sem valvís serótónín endurupptökuhindri (SSRI).
ZA200509132B (en) N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
DK1377550T3 (da) Phenyl-heterocyclyletherderivater som serotonin-re-uptakeinhibitorer